Physician perceptions and experience of current treatment in actinic keratosis

E. Stockfleth; Ketty Peris; C. Guillen; R. Cerio; N. Basset-Seguin; P. Foley; J. Sanches; A. Culshaw; S. Erntoft; M. Lebwohl

doi:10.1111/jdv.12530

Physician perceptions and experience of current treatment in actinic keratosis

E. Stockfleth, Ketty Peris, C. Guillen, R. Cerio, N. Basset-Seguin, P. Foley, J. Sanches, A. Culshaw, S. Erntoft, M. Lebwohl

Research output: Contribution to journal › Article

20 Citations (Scopus)

Abstract

Topical therapy is important in the treatment of actinic keratosis (AK), a major risk factor for, and early development stage of, squamous cell carcinoma. Despite this, research addressing the limitations and challenges associated with topical field therapy in actinic keratosis is lacking.

Original language	English
Pages (from-to)	N/A-N/A
Journal	Journal of the European Academy of Dermatology and Venereology
DOIs	https://doi.org/10.1111/jdv.12530
Publication status	Published - 2014

Keywords

actinic keratosis

Access to Document

10.1111/jdv.12530

Cite this

@article{7cf79fdb811446c286133a0fb9fd9ceb,

title = "Physician perceptions and experience of current treatment in actinic keratosis",

abstract = "Topical therapy is important in the treatment of actinic keratosis (AK), a major risk factor for, and early development stage of, squamous cell carcinoma. Despite this, research addressing the limitations and challenges associated with topical field therapy in actinic keratosis is lacking.",

keywords = "actinic keratosis, actinic keratosis",

author = "E. Stockfleth and Ketty Peris and C. Guillen and R. Cerio and N. Basset-Seguin and P. Foley and J. Sanches and A. Culshaw and S. Erntoft and M. Lebwohl",

year = "2014",

doi = "10.1111/jdv.12530",

language = "English",

pages = "N/A--N/A",

journal = "Journal of the European Academy of Dermatology and Venereology",

issn = "0926-9959",

publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Physician perceptions and experience of current treatment in actinic keratosis

AU - Stockfleth, E.

AU - Peris, Ketty

AU - Guillen, C.

AU - Cerio, R.

AU - Basset-Seguin, N.

AU - Foley, P.

AU - Sanches, J.

AU - Culshaw, A.

AU - Erntoft, S.

AU - Lebwohl, M.

PY - 2014

Y1 - 2014

N2 - Topical therapy is important in the treatment of actinic keratosis (AK), a major risk factor for, and early development stage of, squamous cell carcinoma. Despite this, research addressing the limitations and challenges associated with topical field therapy in actinic keratosis is lacking.

AB - Topical therapy is important in the treatment of actinic keratosis (AK), a major risk factor for, and early development stage of, squamous cell carcinoma. Despite this, research addressing the limitations and challenges associated with topical field therapy in actinic keratosis is lacking.

KW - actinic keratosis

UR - http://hdl.handle.net/10807/60927

U2 - 10.1111/jdv.12530

DO - 10.1111/jdv.12530

M3 - Article

SN - 0926-9959

SP - N/A-N/A

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

ER -

Physician perceptions and experience of current treatment in actinic keratosis

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this